| |
|
|
| |
|
|
| |
| |
hum-molgen: events in
bioscience and medicine |
|
| |
September, 14 2026 |
your calendar for events in genetics, biotechnology
and medicine |
|
| |
|
|
|
|
|
|
| |
advertisement |
|
search meetings |
|
recent postings |
|
|
|
|
| |
=> advertise at hum-molgen
|
|
|
|
| - |
No two clinical trials are the same, and therefore patient support can't be one-size-fits-all. Some patient populations, whether facing a rare disease, a difficult oncology diagnosis or significant tr: Improve Clinical Trial Retention with Patient Population Support |
| - |
Cardiovascular outcomes trials (CVOTs) are among the most complex and resource-intensive studies in drug development, where operational execution can significantly affect timelines, capital efficiency: Why CVOTs Require a Different Approach: Optimizing Event Accrual to Reduce Trial Delays |
| - |
Finding the right participants remains one of the biggest challenges in clinical research. Precision recruitment offers a more targeted, data-informed approach, helping researchers understand who may : Accelerate Participant Identification with Precision Recruitment |
| - |
Pharmacovigilance intake processes must keep pace with the growing volume and variety of incoming data. Potential adverse events and product quality complaints can arrive through emails, lab reports, : Improve Pharmacovigilance Quality with AI-Enabled Case Intake |
| - |
Early-phase clinical development is becoming increasingly complex, requiring sponsors to generate robust proof-of-concept data while navigating evolving study designs, diverse patient populations and : Accelerating Proof-of-Concept for Complex Early-Phase Studies |
| - |
The latest innovations in cell bank manufacturing can help accelerate biologic therapeutics program while reducing risk and simplifying overall strategy. As industry expectations continue to evolve, e: Reduce Cell Bank Manufacturing Risk and Accelerate Characterization |
| - |
Bispecific antibodies are among the most promising and most demanding modalities in biologics today. Their dual-targeting architecture introduces molecular complexity that monoclonal antibody platform: An Integrated Approach to De-Risking Bispecific Antibody Development |
| - |
Clinical trial feasibility has long been constrained by the same fundamental problem: the data used to estimate patient availability rarely reflects the patients who will actually enroll. Site surveys: Feasibility Without Guesswork: Unlocking Genomic and Real-World Data for Faster Study Execution |
| - |
From Robust Clone Outgrowth to GMP-Ready Cell Banks Ensuring the clinical reliability of iPSC-derived products begins with genetically stable and well-characterized starting materials. This webinar pr: Optimizing Single-Cell Cloning Workflows for iPSC Manufacturing |
| - |
Weight-loss medications work only while patients keep taking them. The real goal is staying on medication long enough to achieve meaningful, functional weight loss and sustain it. This webinar explore: Beyond Biometrics: Connecting Behavioral Profiles to Achieve the Right Kind of Weight Loss |
 Get the latest news as RSS feed
|
|
| |
|
|
|
|
|
|
| |
news alert (free) |
|
write an announcement |
|
other resources |
|
| |
|
|
|
|
|
|
| |
To receive our regular news
alert (free - including summary of recent position postings) please register at our
bulletin board.
|
|
Please use our webform for direct postings after you have been set up your account.
By using this site you reach more than
8.000 news alert subscribers and 150.000 HUM-MOLGEN web users and
several mirror sites (e.g. Calender
of Events) in the US, China, Israel and France.
To further improve "hum-molgen: events in bioscience and
medicine" we have redesigned our database and web submission
form. The updated version enables the set up of accounts. By this
way advertisers are in the position to change postings and to submit
multiple postings more efficient. Please report potential problems
/ suggestions for further improvements to the www administrator Kai Garlipp (kai+www@garlipp.de).
|
|
HGMIS Calendar
of Genetic Meetings and Training
Calendar
LifeSciencesInfo.com
How to
Attend a Meeting by Dave Barry
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|